Access cutting-edge opioid-use disorder treatment through this clinical trial at a research site in Wauwatosa. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Wauwatosa location
Preparing your pre-screening questions…
Access opioid-use disorder specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related opioid-use disorder treatment provided free
Check if you qualify for this opioid-use disorder clinical trial in Wauwatosa, WI
No-Cost Study Care
Local to Wauwatosa
Convenient for WI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Combatting the rise of the opioid epidemic is a central challenge of U.S. health care policy. A promising approach for improving welfare and decreasing medical costs of people with substance abuse disorders is offering incentive payments for healthy behaviors. This approach, broadly known as "contingency management" in the medical literature, has repeatedly shown to be effective in treating substance abuse. However, the use of incentives by treatment facilities remains extremely low. Furthermore, it is not well understood how to design optimal incentives to treat opioid abuse. This project will conduct a randomized evaluation of two types of dynamically adjusting incentive schedules for people with opioid use disorders or cocaine use disorders: "escalating" schedules where incentive amounts increase with success to increase incentive power, and "de-escalating" schedules where incentive amounts decrease with success to improve incentive targeting. Both schemes are implemented with a novel "turnkey" mobile application, making them uniquely low-cost, low-hassle, and scalable. Effects will be measured on abstinence outcomes, including longest duration of abstinence and the percentage of negative drug tests. In combination with survey data, variation from the experiment will shed light on the barriers to abstinence more broadly and inform the understanding of optimal incentive design.
Sponsor: Wake Forest University Health Sciences
Yes, this clinical trial (NCT04927143) has an active research site in Wauwatosa, WI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for opioid-use disorder treatment options in Wauwatosa, WI, this clinical trial (NCT04927143) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Wauwatosa research site is actively enrolling participants for this clinical trial. You'll receive care from experienced opioid-use disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all opioid-use disorder clinical trials near you to find additional studies recruiting in your area.
See all osteogenesis imperfecta clinical trials recruiting in Wauwatosa — not just this study.
Browse Osteogenesis Imperfecta Trials in Wauwatosa →